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In contrast to other retroviruses of the oncovirinae subgroup, the primate and bovine leukemia viruses (HTLV, STLV, and
BLV) encode genes in the X-region of the genome, between the env gene and the 3* long terminal repeat. In HTLV-I, two
overlapping open reading frames (ORFs) in the distal half of the X-region encode tax and rex genes, while two ORFs (X-I
and X-II) in the proximal half of this region potentially encode proteins designated p12XI (or rof) and p30XII (or tof). The
biological functions and mechanisms of tax and rex have been studied extensively whereas the roles of the other ORFs
have not yet been established. To identify possible functions for ORFs X-I and X-II, an infectious molecular clone of HTLV-
I and a mutant provirus lacking these ORFs were compared with respect to virus replication, gene expression, and ability
to immortalize primary T-cells. When transiently transfected into 293 cells, both intact and deleted proviruses directed
the synthesis of virus mRNAs and proteins that were quantitatively and qualitatively identical. These viruses were also
indistinguishable in their abilities to infect and replicate in DBS-FRhL cells, which are permissive for HTLV-I propagation.
Immortalized T-cell lines were established after cell-free or coculture methods for infection of activated, human peripheral
blood or cord blood lymphocytes with each of the cloned viruses. The growth kinetics, cytokine dependence, and cell
surface markers of the infected T-cell cultures were similar for each provirus clone. Thus, ORFs X-I and X-II are not essential
for virus infectivity, replication, gene expression, or T-cell immortalization in vitro.
INTRODUCTION tively (Felber et al., 1985; Inoue et al., 1987; Fujisawa et
al., 1985; Sodroski et al., 1984; McGuire et al., 1993).
Human T-cell leukemia virus type I (HTLV-I) is the etio-
HTLV-I contains two additional open reading frames
logic agent of adult T-cell leukemia and progressive neu-
(ORFs) in the proximal half of the X-region that have
rological disorders collectively referred to as HTLV-I-as-
been referred to as ORFs X-I and X-II (Seiki et al., 1983).
sociated myelopathy/tropical spastic paraparesis (HAM/
Alternative splicing produces unique mRNAs containing
TSP) (Gessain et al., 1985; Poiesz et al., 1980; Osame et
ORFs X-I and X-II whose predicted translation products
al., 1986; Yoshida et al., 1982; Franchini, 1995). HTLV-I
have been designated p12X-I (rof), p30X-II (tof), and p13X-II
transforms predominantly CD4/ T-cells in vivo although
(Ciminale et al., 1992; Koralnik et al., 1992; Berneman et
other cell types are infected both in vivo and in vitro
al., 1992). The mRNAs capable of encoding ORFs X-I
(Poiesz et al., 1980; Hattori et al., 1981; De Rossi et al.,
and X-II have been detected in infected cell lines, in
1985; Richardson et al., 1990; Clapham et al., 1983; Ho lymphocytes from infected individuals, and in cells trans-
et al., 1984; Hoxie et al., 1984; Longo et al., 1984; Mann fected with HTLV-I provirus clones. Relative to other viral
et al., 1984; Hoffman et al., 1992). HTLV-I, with HTLV-II, mRNAs, the levels of these alternatively spliced mRNAs
simian T-cell leukemia viruses, and bovine leukemia vi- are extremely low and their putative proteins have not
rus form a unique subgroup of oncoretroviruses charac- been detected in infected cells (Caputo and Haseltine,
terized by a unique genome organization and coding 1992). The p12 and p30 proteins of HTLV-I have been
potential. Unlike the less complex oncoretroviruses, the ectopically expressed from plasmids in transfected cells
HTLV group of retroviruses contains several open read- in order to study their subcellular localization and interac-
ing frames in a region located between the envelope tions with cellular proteins (Koralnik et al., 1993, 1995).
gene and the 3* long terminal repeat (Fig. 1). The overlap- The conservation of predicted amino acid sequences of
ping tax and rex genes, located in the distal half of this ORFs X-I and X-II among HTLV-I isolates as well as the
region, have been extensively characterized and shown presence of distantly related ORFs in HTLV-II and BLV
to regulate transcription of cellular and virus promoters suggest that they are important for virus propagation in
and to mediate nuclear export of viral mRNAs, respec- nature (Ciminale et al., 1992, 1995, 1997; Alexandersen
et al., 1993; Willems et al., 1994). However, their functions
have yet to be established.1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (301) 846-7034. E-mail: derse@ncifcrf.gov. The development of an infectious molecular clone of
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HTLV-I, combined with improved infection and transient dishes and then passaged every 5 days at a 1:5 dilution.
transfection methods, provides new opportunities to ex- Aliquots were examined by p19 antigen capture ELISA
amine HTLV-I gene function (Derse et al., 1996). In an (Cellular Products) at each passage.
attempt to define biologic functions for the X-region Normal human peripheral blood and cord blood mono-
ORFs, we constructed HTLV-I proviruses in which ORFs nuclear cells were obtained by centrifugation of hepera-
X-I and X-II have been mutated or deleted. These viruses nized blood on a Ficoll density gradient (Organon Tech-
were compared with respect to their gene expression, nika, Durham, NC). Cells were activated in RPMI 1640
infectivity, and replication in vitro. We have established medium supplemented with 10% fetal bovine serum, 100
immortalized T-cell lines after infections of primary hu- mg each of penicillin and streptomycin, 1 mg per ml phyto-
man lymphocytes by both cell-free and coculture infec- hemagglutinin (Burroughs Welcome, Research Triangle
tion methods with cloned HTLV-I proviruses and have Park, NC), and 10% delectinated, partially purified human
tested the ability of the mutated proviruses to immortalize IL-2 (Cellular Products, Buffalo, NY) for 72 hr at 377 in a 5%
primary T-cells in vitro. CO2 incubator. Cell-free infections of lymphocytes were
performed by two different methods, both resulting in
establishment of immortalized T-cell lines. SupernatantsMATERIALS AND METHODS
from transiently transfected 293 cells were filtered
Plasmids. The cloning and construction of the plasmid through 0.45-mm filters (Millipore). Lymphocytes (51 106)
pCS-HTLV has been described previously, and it was were suspended in 1 ml of filtered supernatant and incu-
demonstrated to encode an infectious HTLV-I provirus bated for 4 hr at 377. Cells were collected by centrifuga-
(Derse et al., 1995, 1996). The PstI to SstII fragment, tion, suspended in 10 ml of complete medium, and trans-
spanning nucleotides 6750 to 7136 of pCS-HTLV and ferred to T25 culture flasks. Cells were maintained at a
containing the ORFs X-I and X-II, was replaced with a density of 5 1 105 cells per milliliter and medium was
synthetic XbaI linker to produce pHTLV-DPSX. ORF X-I replenished weekly. The second approach for cell-free
of the provirus clone pCS-HTLV was found to contain a infections utilized transwell plates (Costar). DBS-FRhL
premature stop codon. Therefore, the PstI to SstII frag- cells persistently infected with HTLV-I were plated at
ment containing ORFs X-I and X-II of pCS-HTLV was re- approximately 30% confluence in the bottom chamber of
placed with the homologous fragment generated by RT- a 6-well plate. Transwells (0.45 mm) containing activated
PCR of mRNA derived from MT2 cells. MT2 cell mRNA lymphocytes (21 105 per milliliter) were placed in contact
was converted to cDNA with random hexamer primers
with the fluid in the lower chambers and cells were al-
and then amplified with primers flanking the PstI and
lowed to proliferate in the presence of continuously pro-
SstII sites at positions 6750 and 7136, respectively. The
duced virus for 3 days. Lymphocytes were then trans-
PCR product was digested with PstI and SstII and ligated
ferred to T25 flasks and cultured as above.into pCS-HTLV. Sequence analysis confirmed that ORFs
Northern blotting. Transfected or infected cells wereX-I and X-II of pCS-X1MT matched published sequences
collected and suspended in lysis buffer containing: 10and are thus theoretically capable of translation.
mM Tris–HCl, pH 7.5; 150 mM NaCl; 0.5% Nonidet P40;Cell lines and transfections. Human 293 cells and DBS-
and 1.5 mM MgCl2 . The cytoplasmic supernatant wasFRhL cells (clone B5) were maintained in Dulbecco’s
extracted with RNA STAT 50LS (Tel-Test Inc.) and RNAmodified medium supplemented with 10% fetal calf se-
was precipitated with ethanol. Poly(A)/ mRNA was pre-rum. HTLV-I-transformed T-cells were maintained in
pared and run on 1% agarose/0.67 M formaldehyde gelsRPMI 1640 supplemented with 10% fetal calf serum and
and blotted with labeled tax probe as previously de-10% partially purified human IL-2 (Cellular Products, Buf-
scribed (Martarano et al., 1994).falo, NY). For transfections, 293 cells were plated at 2 1
Western immunoblotting. Culture media from HTLV-I-106 cells in a 10-cm dish the day prior to transfection.
infected cells were collected and cleared of cell debrisPlasmid DNA (10 mg) was applied to the cells for 6 hr
by low-speed centrifugation and filtration through a 0.45-as calcium phosphate coprecipitates. Two days after
mm filter. Supernatant was then underlaid with 2.5 mltransfection cells and supernatants were collected for
of 20% glycerol in phosphate-buffered saline in 10 mlanalysis of viral mRNAs and proteins.
Oakridge tubes and centrifuged for 90 min at 30,000 RPMInfections. DBS-FRhL (clone B5) cells were infected
in a Ti70.1 rotor. Virus pellets were dissolved in 100with filtered supernatants from transiently transfected
ml of SDS sample buffer; 50 ml was loaded onto 12.5%293 cells. Supernatants were collected from 293 cells 2
acrylamide–SDS gels and then electrophoretically trans-days after transfection, cleared of cell debris by low-
ferred to Immobilon (Millipore) filters as previously de-speed centrifugation, filtered through a 0.45-mm filter, and
scribed (Martarano et al., 1994). Filters were incubatedapplied to 3.5-cm dishes containing DBS-FRhL cells.
with rabbit antipeptide antisera to HTLV-I gag proteinsDBS-FRhL cells were plated the previous day at 3 1 105
p24 (CA), p19 (MA), and p15 (NC) followed by goat anti-cells per dish. Five days after infection, cells from each
3.5-cm dish were trypsinized and transferred to 10-cm rabbit antibody conjugated to horseradish peroxidase
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FIG. 1. Genomic organization and location of ORFs X-I and X-II in the molecular clones of HTLV-I. ORFs X-I and X-II are located in the proximal
X-region of the virus, between the env gene and the 3* LTR. Construction of pCS-HTLV was described previously. In the course of this work it was
discovered that a premature stop codon is present in ORF X-I of this clone (marked by an asterisk). The persistently infected T-cell line, MT2, was
used as the source of mRNA to prepare cDNA for amplification with primers flanking ORFs X-I and X-II. The PCR product was digested with PstI
and SstII and replaced the analogous region in pCS-HTLV to yield pCS-X1MT. The deletion mutant, pHTLV-DPSX, was made by deleting the PstI
to SstII fragment and replacing it with a synthetic XbaI linker.
and visualized by enhanced chemiluminescence (ECL, with each of the three provirus clones. Two days after
transfection cellular RNA was extracted and examinedAmersham).
by Northern blotting with an HTLV-I tax/rex probe (Fig. 2).
Nearly identical levels of virus mRNAs were expressed inRESULTS
transfected cells and typical patterns of the three major
The cloning and construction of pCS-HTLV, which con- viral mRNAs were observed. The unspliced and singly
tains an infectious, full-length HTLV-I provirus, has been spliced mRNAs produced in cells transfected with
described (Derse et al., 1995, 1996). Sequence analysis pHTLV-DPSX are predicted to be 386 nucleotides
of the X region of pCS-HTLV revealed several differences smaller than the mRNAs expressed from the other provi-
compared with published sequences, including a prema- ruses. At the same time, cells were collected for RNA
ture stop codon in ORF X-I. ORFs X-I and X-II in pCS- preparation and supernatants from transfected cells
HTLV were therefore replaced with HTLV-I sequences were analyzed by HTLV-I p19 antigen capture ELISA
expressed in MT2 cells. Cytoplasmic mRNA from MT2 assays, which revealed that virion protein synthesis was
cells was converted to cDNA, and the proximal X region similar for the three proviruses (data not shown). Thus,
was amplified by PCR and ligated into the corresponding the three proviruses were indistinguishable with respect
region of pCS-HTLV to generate pCS-X1MT (Fig. 1). Se- to RNA and protein synthesis in transiently transfected
quence analysis of pCS-X1MT confirmed that ORFs X-I cells, indicating that ORFs X-I and X-II did not affect viral
and X-II were potentially viable. Another provirus clone, gene expression.
pHTLV-DPSX, was constructed by deleting the region A subclone of fetal rhesus lung cells (DBS-FRhL) des-
containing ORF X-I and most of ORF X-II from pCS-HTLV ignated B5 was previously demonstrated to be permis-
(Fig. 1). These three proviruses were then compared with sive for HTLV-I infection and replication (Derse et al.,
respect to gene expression, infectivity, and T-cell immor- 1996). B5 cells can be infected with cell-free virus or
talization. directly transfected with provirus DNA. Approximately 2
In order to determine whether deletion of the region weeks after infection or transfection, HTLV-I gag antigens
containing ORFs X-I and X-II affected synthesis or pro- can be detected in culture supernatants; virus production
plateaus after 4 weeks and remains at high levels there-cessing of viral mRNA, human 293 cells were transfected
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Virus expression in the immortalized T-cells was exam-
ined by immunoblotting supernatants with anti-gag anti-
bodies (Fig. 3B). Again, expression and release of virus
particles into the supernatants were similar for each pro-
virus. Cell surface markers were examined by FACS anal-
ysis and revealed no differences among cultures infected
with pCS-HTLV, pHTLV-DPSX, or pCS-X1MT (Table 1).
The T-cell cultures were all CD4/, CD80, and CD34/,
and CD3 was either absent or very low. All cultures
showed similar growth kinetics and gave identical re-
sponses to cytokines. Thus, ORFs X-I and X-II did not
appear to be involved in HTLV-I-mediated T-cell immor-
talization or proliferation in vitro.
DISCUSSION
HTLV-I ORFs X-I and X-II were dispensable for virus
replication in cell culture and had no discernable effectFIG. 2. Expression of proviral RNAs in transfected 293 cells. Human
on virus gene expression. Primary human lymphocytes293 cells were transfected with the indicated plasmid DNAs by calcium
phosphate coprecipitation. Two days later cells were collected and were successfully infected and immortalized with cell-
poly(A)/ mRNA was prepared and run on 1% agarose/0.67 M formalde- free virus produced from transiently transfected 293 cells
hyde gels, transfered to nylon membrane, and hybridized to a tax frag- or stably infected DBS-FRhL cells expressing the paren-
ment probe. The unspliced (gag/pol), singly spliced (env), and doubly
tal or mutant virus clones. The viruses produced fromspliced (tax/rex) mRNAs are indicated.
DBS-FRhL cells chronically infected with cloned provi-
ruses were capable of infecting naive DBS-FRhL cells
after. The B5 cell culture system thus provides a means and primary T-cells by either cell-free or coculture routes.
to examine HTLV-I infectivity and replication since multi-
ple rounds of infection are required for virus spread
through the culture. B5 cells were infected with filtered
supernatants from transiently transfected 293 cells, and
HTLV-I p19 gag antigen in the culture supernatants was
monitored at weekly intervals. Both the kinetics of ap-
pearance and levels of p19 were similar for the three
viruses (data not shown). Virion proteins released from
the persistently infected cell cultures were compared by
immunoblotting with anti-gag antisera. Virion core pro-
teins were qualitatively and quantitatively similar among
the three virus-infected cultures (Fig. 3A). Virions re-
leased from B5 cells that are persistently infected with
the three cloned viruses were shown to infect both naive
B5 cells and primary human lymphocytes (see below).
Thus, ORFs X-I and X-II did not influence virus infectivity
or replication in DBS-FRhL cells.
Activated human PBMCs and cord blood lymphocytes
were infected with HTLV-I produced from both B5 cells
persistently infected with pCS-HTLV, pHTLV-DPSX, or FIG. 3. Expression and processing of virion structural proteins re-
leased from HTLV-I-infected cell lines. (A) Immunoblot of virions frompCS-X1MT and transiently transfected 293 cells. Either
chronically infected DBS-FRhL (clone B5) cells. Uninfected cells (lanecoculture of activated lymphocytes with HTLV-infected
1); cells persistently infected with pCS-HTLV (lane 2); pCS-X1MT (laneB5 cells or cell-free infection with transfected cell super-
3); or pHTLV-DPSX (lane 4) were grown to confluence in 10-cm dishes.
natants resulted in the continuous proliferation and out- The culture medium was replaced 24 hr before collection. Virus parti-
growth of IL-2-dependent T-cells; in contrast, uninfected cles in culture supernatants were concentrated by ultracentrifugation
through a 20% glycerol cushion and fractionated on 12.5% acrylamide–lymphocytes ceased to proliferate after approximately 6
SDS gels. Membrane-bound proteins were probed with anti-HTLV-Iweeks. T-cells were considered immortalized after at
gag antisera. The gag precursor polyprotein, pr53, and mature proteins,least 12 weeks of continuous growth and in all cases,
p24, p19, and p15, are indicated. (B) Immunoblot of virions from immor-
the HTLV-I immortalized lines have been in culture for at talized T-cell lines infected with: pCS-HTLV (lane 1); pCS-X1MT (lane
least 1 year. All HTLV-I-infected T-cell lines that were 2); and pHTLV-DPSX (lane 3). Virus particles in cell culture superna-
tants were prepared and immunoblotted as in A.established remained IL2-dependent.
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TABLE 1
FACS Analysis of HTLV-I Immortalized T-Cells
Cell surface expressiona
Cell line CD2 CD3 CD4 CD8 CD14 CD16 CD25 CD19
CB/X1MT 95% 7% 95% 0 0 0 89% 0
PBL/X1MT 97% 12% 92% 0 0 0 88% 0
CB/pCS 98% 0 90% 0 0 0 89% 0
CB/DPSX#3 98% 0 90% 0 0 20% 90% 0
CB/DPSX#4 95% 14% 95% 0 0 16% 85% 0
a Immunophenotypic analyses of immortalized T-cell lines were performed 12 to 16 weeks after infection. Cell staining was done in buffer
containing 2% human AB serum to block Fc receptors. All antisera were fluorescein-conjugated and obtained from commercial sources (Becton–
Dickinson and Immunotech). Fluorescent-activated cell sorting was performed on a Coulter Profile instrument according to the manufacturer’s
standard protocols. Results are presented as percentage positive cells.
Immortalized T-cell lines that were obtained after infec- fested as effects on virus spread, lymphocyte trafficking,
or immunological detection; alternatively they may di-tions with either the parental or deleted viruses were
nearly identical and expressed cell surface markers typi- rectly affect cellular transformation or clonal expansion
of infected cells. While studies of HTLV-I propagation andcal of previously established HTLV-I-infected T-cell lines.
All of the T-cell lines that were obtained with the cloned infectivity in animal model systems may show patterns
similar to HTLV-II and BLV, the differences in pathogene-proviruses here were IL2-dependent and expressed CD4,
CD2, and CD25 (IL2Ra) on their surface. sis effected by these viruses suggest that their respective
X-region ORFs may have distinct characteristics.The predicted amino acid sequences of the X region
ORFs are highly conserved among HTLV-I isolates and
analogous ORFs are present in HTLV-II and BLV. There ACKNOWLEDGMENTS
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